Form 4: West Pharmaceutical Services Director Acquires Restricted Stock Units

Director Stephen H. Lockhart acquired 1,071 shares of restricted stock units in West Pharmaceutical Services, Inc.

Summary

• Stephen H. Lockhart, a director of West Pharmaceutical Services Inc., acquired 1,071 shares of common stock on May 6, 2025.
• These shares were received as restricted stock units.
• The restricted stock units will vest in full on the date of the next annual shareholder meeting.
• Following the transaction, Lockhart directly owns 2,708.407 shares of West Pharmaceutical Services Inc. common stock.
• A Power of Attorney was executed on May 16, 2024, granting Luis Cantarero, Louis Lalli, Ryan Metz, and Caitlin Hippeli the authority to file Section 16(a) forms on Lockhart's behalf.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing, indicating a routine transaction. The sentiment is neutral to slightly positive as insider ownership is generally viewed favorably.

Positives

• The acquisition of restricted stock units by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units is tied to the next annual shareholder meeting, suggesting a continued alignment of the director's interests with those of the shareholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder confidence.

Next Steps

• The restricted stock units will vest at the next annual shareholder meeting.

Key Dates

Keywords

Form 4, Section 16(a), West Pharmaceutical Services, Lockhart, Restricted Stock Units, Director, Beneficial Ownership, Power of Attorney